Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-110071
Filing Date
2018-04-06
Accepted
2018-04-06 16:36:58
Documents
14
Period of Report
2018-05-17
Effectiveness Date
2018-04-06

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d626847ddef14a.htm DEF 14A 473054
2 GRAPHIC g6268471internet.jpg GRAPHIC 1532
3 GRAPHIC g6268472call.jpg GRAPHIC 2286
4 GRAPHIC g626847arrow_left.jpg GRAPHIC 44100
5 GRAPHIC g626847arrow_right.jpg GRAPHIC 44672
6 GRAPHIC g626847eemail.jpg GRAPHIC 10387
7 GRAPHIC g626847g21r49.jpg GRAPHIC 1766
8 GRAPHIC g626847g25v11.jpg GRAPHIC 7582
9 GRAPHIC g626847g66r28.jpg GRAPHIC 7471
10 GRAPHIC g626847g84y56.jpg GRAPHIC 6820
11 GRAPHIC g626847g88t53.jpg GRAPHIC 15575
12 GRAPHIC g626847g99b25.jpg GRAPHIC 8830
13 GRAPHIC g626847nwcal.jpg GRAPHIC 1256
14 GRAPHIC g626847ttphone.jpg GRAPHIC 7724
  Complete submission text file 0001193125-18-110071.txt   696369
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36112 | Film No.: 18743612
SIC: 2834 Pharmaceutical Preparations